Delaware
|
77-0632186
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(IRS
Employer
Identification
No.)
|
PART
Ι FINANCIAL INFORMATION
|
1
|
ITEM
1 FINANCIAL STATEMENTS
|
1
|
ITEM
2 MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF
OPERATION
|
17
|
ITEM
3 CONTROLS AND PROCEDURES
|
21
|
PART
ΙΙ. OTHER INFORMATION
|
22
|
ITEM
1 LEGAL PROCEEDINGS
|
22
|
ITEM
2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
|
22
|
ITEM
3 DEFAULTS UPON SENIOR SECURITIES
|
22
|
ITEM
4 SUBMISSION OF MATTERS TO A VOTE OF SECURITY
HOLDERS
|
22
|
ITEM
5 OTHER INFORMATION
|
22
|
ITEM
6 EXHIBITS
|
22
|
SIGNATURES
|
23
|
Condensed
Consolidated Balance Sheet (unaudited)
|
|||||||
Item
|
2007-3-31
|
|
2006-12-31
|
||||
ASSETS
|
|||||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
773,657
|
$
|
498,103
|
|||
Accounts
receivable, net of bad debt allowance of $261,425 and $258,667,
respectively
|
227,140
|
929,446
|
|||||
Inventories
|
869,445
|
541,340
|
|||||
Prepaid
expenses
|
193,390
|
302,007
|
|||||
Other
current assets
|
47,133
|
57,011
|
|||||
Total
current assets
|
2,110,765
|
2,327,907
|
|||||
Property,
Plant and Equipment:
|
|||||||
Buildings
|
1,056,192
|
1,046,116
|
|||||
Machinery
and equipment
|
592,988
|
585,282
|
|||||
Automobiles
|
48,231
|
47,772
|
|||||
Office
equipment
|
81,048
|
78,096
|
|||||
Computer
software
|
9,329
|
9,240
|
|||||
1,787,788
|
1,766,506
|
||||||
Less:
accumulated depreciation
|
(318,684
|
)
|
(286,039
|
)
|
|||
Property
plant and equipment - net
|
1,469,104
|
1,480,467
|
|||||
Construction
in progress
|
65,259
|
34,548
|
|||||
Intangible
asset-net
|
325,152
|
337,027
|
|||||
Deferred
financing costs
|
191,293
|
211,793
|
|||||
Deposit
to purchase the proprietary technology
|
126,443
|
126,443
|
|||||
Total
assets
|
$
|
4,288,016
|
$
|
4,518,185
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY (DEFICIENCY)
|
|||||||
Current
liabilities
|
|||||||
Accounts
payable and accrued expenses
|
$
|
1,277,986
|
$
|
983,980
|
|||
Construction
costs payable
|
312,229
|
366,879
|
|||||
Due
to related parties
|
526,307
|
496,806
|
|||||
Current
portion of bank notes payables
|
5,457
|
5,405
|
|||||
Total
current liabilities
|
2,121,979
|
1,853,070
|
|||||
Long-term
liabilities, less current portion:
|
|||||||
Unsecured
loans payable
|
1,486,903
|
1,472,717
|
|||||
Bank
notes payable
|
-
|
1,351
|
|||||
Long-term
convertible notes payable
|
2,285,524
|
2,365,962
|
|||||
Discount
on warrants relating to long-term convertible notes
|
(1,295,099
|
)
|
(1,371,446
|
)
|
|||
Total
long-term liabilities
|
2,477,328
|
2,468,584
|
|||||
Minority
interest in a subsidiary
|
98,173
|
103,362
|
|||||
Shareholders’
equity (deficiency)
|
|||||||
Common
stock -$0.001 par value
|
|||||||
Authorized
200,000,000 shares and 200,000,000
|
|||||||
shares
at March 31, 2007 and December 31, 2006
|
|||||||
respectively.
Issued and outstanding 72,085,983 and
|
|||||||
70,149,556
shares at March 31, 2007, and December
|
|||||||
31,
2006, respectively
|
72,086
|
70,150
|
|||||
Preferred
stock $0.001 par value
|
|||||||
Authorized
20,000,000 shares, nil shares issued and
|
|||||||
outstanding
at March 31, 2007, and December 31,
|
|||||||
2006,
respectively
|
-
|
-
|
|||||
Additional
paid-in capital
|
8,399,520
|
8,311,975
|
|||||
Stock-based
compensation reserve
|
(477,493
|
)
|
(523,468
|
)
|
|||
Deficit
Accumulated
|
(8,405,914
|
)
|
(7,766,654
|
)
|
|||
Accumulated
other comprehensive income
|
2,337
|
1,166
|
|||||
Total
shareholders’ equity (deficiency)
|
(409,464
|
)
|
93,169
|
||||
Total
liabilities and stockholders’ equity
|
$
|
4,288,016
|
$
|
4,518,185
|
Condensed
Consolidated Statements of Operations and Comprehensive Income
(Unaudited)
|
|||||||
|
Three
Months Ended March 31,
|
||||||
Item
|
2007
|
|
2006
|
||||
Net
sales
|
$
|
1,384,093
|
$
|
11,023
|
|||
Cost
of sales
|
1,245,770
|
7,410
|
|||||
Gross
profit
|
138,323
|
3,613
|
|||||
Operating
expenses:
|
|||||||
Consulting
and professional fees
|
189,461
|
44,400
|
|||||
Officers’
compensation
|
65,042
|
5,967
|
|||||
General
and administrative
|
179,024
|
68,934
|
|||||
Selling
expenses
|
143,625
|
3,288
|
|||||
Research
and development
|
49,304
|
7,901
|
|||||
Depreciation
and amortization
|
31,273
|
33,162
|
|||||
Allowance
and provision
|
266
|
-
|
|||||
Total
costs and expenses
|
657,995
|
163,652
|
|||||
Operating
loss
|
(519,672
|
)
|
(160,039
|
)
|
|||
Interest
expense, net
|
(125,758
|
)
|
(24,404
|
)
|
|||
Minority
interest in a subsidiary’s loss
|
6,171
|
-
|
|||||
Net
loss
|
$
|
(639,259
|
)
|
$
|
(184,443
|
)
|
|
Other
comprehensive income (loss):
|
|||||||
Translation
adjustment
|
(123,794
|
)
|
6,641
|
||||
Comprehensive
loss
|
$
|
(763,054
|
)
|
$
|
(177,802
|
)
|
|
Net
loss per common share
|
|||||||
-basic
and diluted
|
$
|
(0.011
|
)
|
$
|
(0.003
|
)
|
|
Weighted
average number of common
|
|||||||
shares
outstanding
|
|||||||
-basic
and diluted
|
71,794,704
|
59,235,930
|
Condensed Consolidated Statements of Stockholders’ Equity (Deficiency) (Unaudited) | ||||||||||||||||||||||
Common
Stock
|
|
|
|
|||||||||||||||||||
|
Shares
|
Amount
|
|
Additional
Paid-in Capital |
|
Stock-based
Comepensation Reserve |
Accumulated
Deficits
|
Other
Comprehensive income |
Total
Stockholders' Deficiency |
|||||||||||||
Balance,
January 1, 2006
|
59,235,930
|
$
|
59,236
|
4,835,968
|
-
|
(5,482,555
|
)
|
22,358
|
($564,993
|
)
|
||||||||||||
Issuance
of detachable warrants in conjunction with
|
||||||||||||||||||||||
the
advances from a related party dated March 31,
|
||||||||||||||||||||||
2006
|
-
|
-
|
5,145
|
-
|
-
|
-
|
5,145
|
|||||||||||||||
Issuance
of 5 million shares of common stock pursuant
|
||||||||||||||||||||||
to
the Stock Purchase Agreement dated March 10,
|
||||||||||||||||||||||
2006
|
5,000,000
|
5,000
|
740,416
|
-
|
-
|
-
|
745,416
|
|||||||||||||||
Issuance
of detachable warrants in conjunction with
|
||||||||||||||||||||||
the
issuance of convertible promissory notes on June
|
||||||||||||||||||||||
29,
2006, August 15, 2006 and October 31, 2006
|
-
|
-
|
1,467,956
|
-
|
-
|
-
|
1,467,956
|
|||||||||||||||
Issuance
of warrants to a financing consultant in June,
|
||||||||||||||||||||||
August
and October 2006
|
-
|
-
|
231,544
|
(231,544
|
)
|
-
|
-
|
-
|
||||||||||||||
Amortization
of fair value of warrants to a financing
|
||||||||||||||||||||||
consultant
in 2006
|
-
|
-
|
-
|
30,801
|
30,801
|
|||||||||||||||||
Issuance
of common stock for exercise of warrants on
|
||||||||||||||||||||||
July
6, 2006
|
50,000
|
50
|
(50
|
)
|
-
|
-
|
-
|
-
|
||||||||||||||
Issuance
of common stock for exercise of warrants on
|
||||||||||||||||||||||
August
9, 2006
|
500,000
|
500
|
8,500
|
-
|
-
|
-
|
9,000
|
|||||||||||||||
Issuance
of common stock as compensation to an
|
||||||||||||||||||||||
investor
relation consultant on October 10, 2006
|
1,800,000
|
1,800
|
430,200
|
-
|
-
|
-
|
432,000
|
|||||||||||||||
Issuance
of common stock as compensation to an
|
||||||||||||||||||||||
officer
on October 10, 2006
|
996,646
|
997
|
45,355
|
-
|
-
|
-
|
46,352
|
|||||||||||||||
Issuance
of common stock for exercise of warrants on
|
||||||||||||||||||||||
October
10, 2006
|
350,000
|
350
|
7,350
|
-
|
-
|
-
|
7,700
|
|||||||||||||||
Issuance
of common stock for exercise of warrants on
|
||||||||||||||||||||||
October
10, 2006
|
750,000
|
750
|
16,500
|
-
|
-
|
-
|
17,250
|
|||||||||||||||
Issuance
of common stock for conversion of a
|
||||||||||||||||||||||
convertible
note on November 10, 2006
|
773,537
|
774
|
112,936
|
-
|
-
|
-
|
113,710
|
|||||||||||||||
Employee
stock option granted on December 12, 2006
|
-
|
-
|
326,810
|
(326,810
|
)
|
-
|
-
|
-
|
||||||||||||||
Amortization
of fair value of employee stock option
|
||||||||||||||||||||||
granted
in 2006
|
-
|
-
|
-
|
4,085
|
-
|
-
|
4,085
|
|||||||||||||||
Issuance
of common stock for conversion of principal
|
||||||||||||||||||||||
of
6% Notes in the fourth quarter of 2006
|
693,443
|
693
|
83,345
|
-
|
-
|
-
|
84,038
|
|||||||||||||||
Net
loss for the year ended December 31, 2006
|
-
|
-
|
-
|
-
|
(2,284,099
|
)
|
-
|
(2,284,099
|
)
|
|||||||||||||
Other
comprehensive income for the year ended
|
||||||||||||||||||||||
December
31, 2006
|
-
|
-
|
-
|
-
|
-
|
(21,192
|
)
|
(21,192
|
)
|
|||||||||||||
Balance,
December 31, 2006
|
70,149,556
|
70,150
|
8,311,975
|
(523,468
|
)
|
(7,766,654
|
)
|
1,166
|
93,168
|
|||||||||||||
Issuance
of common stock for exercise of warrants on
|
||||||||||||||||||||||
January
5, 2007
|
1,000,000
|
1,000
|
(1,000
|
)
|
0
|
|||||||||||||||||
Issuance
of common stock for conversion of principal
|
||||||||||||||||||||||
and
interest of 6% Notes in the first quarter of 2007
|
936,427
|
936
|
88,545
|
89,482
|
||||||||||||||||||
Amortizaton
of fair value of warrants to a financing
|
||||||||||||||||||||||
consultant
in 2006
|
19,295
|
19,295
|
||||||||||||||||||||
Amortization
of fair value of employee stock option
|
||||||||||||||||||||||
granted
in 2006
|
26,680
|
26,680
|
||||||||||||||||||||
Net
loss for three months ended March 31, 2007
|
(639,259
|
)
|
(639,259
|
)
|
||||||||||||||||||
Other
comprehensive income for three months ended
|
||||||||||||||||||||||
March
31, 2007
|
1,171
|
1,171
|
||||||||||||||||||||
Balance,
March 31, 2007
|
72,085,983
|
$
|
72,086
|
8,399,520
|
(477,493
|
)
|
(8,405,914
|
)
|
2,337
|
($409,464
|
)
|
Condensed Consolidated Statements of Cash Flows (Unaudited) | |||||||
Three
Months Ended March 31,
|
|||||||
Item
|
2007
|
2006
|
|||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(639,259
|
)
|
$
|
(184,443
|
)
|
|
Adjustments
to reconcile net loss to net cash used in
|
|||||||
operating
activities:
|
|||||||
Depreciation
and amortization
|
176,233
|
33,867
|
|||||
Amortization
of detachable warrants and option
|
122,322
|
980
|
|||||
Provision
for doubtful debt and inventory impairment
|
2,758
|
-
|
|||||
Minority
interest in subsidiary
|
(6,171
|
)
|
-
|
||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable
|
699,548
|
(4,379
|
)
|
||||
Inventories
|
(328,105
|
)
|
5,036
|
||||
Prepaid
expenses
|
617
|
462
|
|||||
Other
current assets
|
9,878
|
(5,383
|
)
|
||||
Accounts
payable and accrued expenses
|
297,953
|
65,939
|
|||||
Net
cash provided by (used in) operating activities
|
335,774
|
(91,546
|
)
|
||||
Cash
flows from investing activities:
|
|||||||
Purchase
of property and equipment
|
(89,493
|
)
|
(3,625
|
)
|
|||
Net
cash used in investing activities
|
(89,493
|
)
|
(3,625
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Proceeds
from subscription of common stock
|
-
|
126,284
|
|||||
Proceeds
from related parties
|
55,818
|
44,268
|
|||||
Repayment
to related parties
|
(47,085
|
)
|
-
|
||||
Repayment
of convertible notes payable
|
-
|
(87,135
|
)
|
||||
Repayment
of long-term borrowings
|
(1,364
|
)
|
(2,004
|
)
|
|||
Net
cash provided by financing activities
|
7,369
|
81,413
|
|||||
Effect
of exchange rate changes on cash and cash
equivalents
|
21,904
|
9,088
|
|||||
Cash
and cash equivalents:
|
|||||||
Net
increase (decrease)
|
275,554
|
(1,045
|
)
|
||||
Balance
at beginning of period
|
498,103
|
14,576
|
|||||
Balance
at end of period
|
$
|
773,657
|
$
|
13,531
|
|||
Supplemental
Disclosures of Cash flow Information:
|
|||||||
Cash
paid for interest
|
$
|
-
|
$
|
23,306
|
|||
Cash
paid for taxes
|
$
|
-
|
$
|
-
|
|||
Non-cash
investing and financing activities:
|
|||||||
Issuance
of detachable warrants in conjunction with loans
|
$
|
-
|
$
|
5,145
|
|||
Issuance
of common stock for long-term convertible notes
|
|||||||
payable
and interest
|
$
|
89,482
|
$
|
-
|
|||
Non-cash
exercise of warrants
|
$
|
1,000
|
$
|
-
|
1. |
Background
and Basis of
Presentation
|
Buildings
|
20-35
years
|
Machinery
and equipment
|
4-12
years
|
Automobiles
|
8
years
|
Office
equipment
|
5
years
|
Computer
software
|
3
years
|
2. |
Recent
Accounting
Pronouncements
|
3. |
Accounts
Receivable
|
4. |
Inventories
|
Item
|
March
31,
2007
|
December
31,
2006
|
|||||
Raw
materials
|
$
|
685,761
|
$
|
439,397
|
|||
Semi-Finished
goods
|
187
|
241
|
|||||
Finished
goods
|
183,061
|
101,271
|
|||||
Raw
materials contracted for processing
|
436
|
431
|
|||||
Total
|
$
|
869,445
|
$
|
541,340
|
5. |
Prepaid
expenses
|
Item
|
March
31, 2007
|
December
31, 2006
|
|||||
Prepaid
stock-based compensation
|
|||||||
for
investor relation consultant (i)
|
148,800
|
256,800
|
|||||
Prepaid
charges relating to urea entrepot trade
|
30,097
|
30,097
|
|||||
Others
|
14,493
|
15,110
|
|||||
Total
|
193,390
|
302,007
|
6. |
Property,
Plant and Equipment
|
7. |
Intangible
Assets
|
Expected
Amortization Period started on the purchase date of August 1,
2004
|
Gross
carrying value
|
Accumulated
amortization
|
Net
value
at
March 31, 2007
|
|
Patent
|
8.5
years
|
$480,411
|
$155,259
|
$325,152
|
Future
expected amortization
|
Amount
|
|||
2007
|
$
|
43,035
|
||
2008
|
57,380
|
|||
2009
|
57,380
|
|||
2010
|
57,380
|
|||
2011
|
57,380
|
|||
Thereafter
|
$
|
52,597
|
8. |
Deferred
Financing Costs
|
9. |
Deposit
to Purchase the Proprietary
Technology
|
10. |
Accounts
Payable and Accrued
Expenses
|
March
31,
|
December
31,
|
||||||
Item
|
2007
|
2006
|
|||||
Consulting
and professional payables
|
$
|
350,821
|
$
|
419,835
|
|||
Payables
to material suppliers
|
316,651
|
99,263
|
|||||
Interest
payable
|
112,399
|
80,775
|
|||||
Salary
payable
|
98,025
|
71,793
|
|||||
Social
insurance payable
|
89,793
|
89,290
|
|||||
Office
rental payable
|
69,014
|
54,926
|
|||||
Payables
to equipment suppliers
|
17,733
|
14,222
|
|||||
Payables
to Kiwa & CAU R&D center
|
58,183
|
25,612
|
|||||
Credit
card balance
|
71,899
|
69,554
|
|||||
Rebates
payable to customers
|
27,701
|
40,651
|
|||||
Others
|
65,767
|
18,058
|
|||||
Total
|
$
|
1,277,986
|
$
|
983,980
|
11.
|
Construction
Costs Payable
|
12. |
Related
Party Transactions
|
Item
|
Notes
|
March
31,
2007
|
December
31,
2006
|
|||||||
Mr.
Wei Li (“Mr. Li”)
|
(i)
|
|
$
|
62,116
|
$
|
32,398
|
||||
China
Star Investment Management Co., Ltd.
(“China
Star”)
|
(ii)
|
|
464,191
|
464,408
|
||||||
Total
|
$
|
526,307
|
$
|
496,806
|
13. |
Unsecured
Loans Payable
|
Item
|
March
31,
2007
|
December
31, 2006
|
|||||
Unsecured
loan payable to Zoucheng Municipal Government, non-interest bearing,
becoming due within three years from Kiwa Shandong’s first profitable year
on a formula basis, interest has not been imputed due to the
undeterminable repayment date
|
$
|
1,163,663
|
$
|
1,152,561
|
|||
Unsecured
loan payable to Zoucheng Science & Technology Bureau, non-interest
bearing, it is due in Kiwa Shandong’s first profitable year, interest has
not been imputed due to the undeterminable repayment date
|
323,240
|
320,156
|
|||||
Total
|
$
|
1,486,903
|
$
|
1,472,717
|
14. |
Long-Term
Convertible Notes
Payable
|
15. |
Equity-Based
Transactions
|
16. |
Stock-based
Compensation
|
17. |
Segment
Reporting
|
Item
|
Bio-
fertilizer
|
Livestock
Feed
|
Urea
trade
|
|
Corporate
|
Total
|
||||||||||
Quarter
ended March 31, 2007
|
||||||||||||||||
Net
sales
|
11,976
|
1,372,117
|
-
|
-
|
1,384,093
|
|||||||||||
Gross
profit
|
2,863
|
135,460
|
-
|
-
|
138,323
|
|||||||||||
Operating
expenses
|
87,607
|
166,361
|
48,458
|
355,569
|
657,995
|
|||||||||||
Operating
profit (loss)
|
(84,744
|
)
|
(30,901
|
)
|
(48,458
|
)
|
(355,569
|
)
|
(519,672
|
)
|
||||||
Interest
income (expense)
|
(9,019
|
)
|
46
|
-
|
(116,785
|
)
|
(125,758
|
)
|
||||||||
Minority
interest in subsidiary
|
-
|
6,171
|
-
|
-
|
6,171
|
|||||||||||
Net
income (loss)
|
(93,763
|
)
|
(24,684
|
)
|
(48,458
|
)
|
(472,354
|
)
|
(639,259
|
)
|
||||||
Total
assets, as of March 31,2007
|
2,141,060
|
840,769
|
833,104
|
473,083
|
4,288,016
|
|||||||||||
Quarter
ended March 31, 2006
|
||||||||||||||||
Net
sales
|
11,023
|
-
|
-
|
-
|
11,023
|
|||||||||||
Gross
profit
|
3,614
|
-
|
-
|
-
|
3,614
|
|||||||||||
Operating
expenses
|
99,901
|
-
|
-
|
63,751
|
163,652
|
|||||||||||
Operating
profit (loss)
|
(96,288
|
)
|
-
|
-
|
(63,751
|
)
|
(160,039
|
)
|
||||||||
Interest
income (expense)
|
4,839
|
-
|
-
|
19,566
|
24,404
|
|||||||||||
Other
income
|
-
|
-
|
-
|
-
|
-
|
|||||||||||
Net
income (loss)
|
(101,127
|
)
|
-
|
-
|
(83,317
|
)
|
(184,443
|
)
|
||||||||
|
-
|
-
|
-
|
|||||||||||||
Total
assets, as of March 31, 2006
|
3,094,281
|
-
|
-
|
7,795
|
3,102,076
|
(1) |
Beijing
Representative Office of Kiwa Shandong fulfills part of our corporate
managerial function. Most of its expenses relating to this function
were
categorized under the corporate heading.
|
18. |
Commitments
and
Contingencies
|
Fiscal
year
|
Amount
|
|
2007
|
$
|
136,809
|
2008
|
99,287
|
|
2009
|
51,718
|
|
Total
|
$
|
287,814
|
19. |
Subsequent
Event
|
Exhibit
No.
|
Description
|
Incorporated
by Reference in Document
|
Exhibit
No. in Incorporated Document
|
|||
3.1
|
Certificate
of Incorporation, effective as of July 21, 2004.
|
Form
8-K filed on July 23 2004
|
3.1
|
|||
3.2
|
Bylaws,
effective as of July 22, 2004.
|
Form
8-K filed on July 23, 2004
|
3.2
|
|||
3.3
|
Certificate
of Amendment to Certificate of Incorporation, effective as of September
27, 2006.
|
Form
10-QSB filed on November 15, 2006
|
3.3
|
|||
10.58
|
Consulting
Agreement dated April 9, 2007, between Kiwa Bio-Tech Products Group
Corporation and First Trust Group, Inc.
|
Filed
herewith
|
||||
21
|
List
of Subsidiaries
|
Form
10-KSB filed on April 2, 2007
|
||||
31.1
|
Certification
of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)
of the
Securities Exchange Act of 1934
|
Filed
herewith.
|
||||
31.2
|
Certification
of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)
of the
Securities Exchange Act of 1934
|
Filed
herewith.
|
||||
32.1
|
Certification
of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as
adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Filed
herewith.
|
||||
32.2
|
Certification
of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as
adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Filed
herewith.
|
/s/Wei Li
Wei Li
|
May 14, 2007
|
Chief
Executive Officer and Chairman of the Board of Directors
(Principal
Executive Officer)
|
||
/s/ Lian jun Luo
Lian jun Luo
|
May 14, 2007 | Chief Financial Officer
and
Director
(Principal
Financial Officer and Principal Accounting Officer)
|